NEtwork to Control ATherothrombosis (NEAT Registry)

Hospital do Coracao

Status: Active, not recruiting

Conditions: Coronary Artery Disease; Atherothrombosis; Peripheral Arterial Disease

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04677725

NEAT (Other Grant/Funding Number)

Details and patient eligibility

About

NEAT is an observational cohort (Prospective registry of real world data) of patients with coronary and peripheral artery disease in an outopatient setting.

Full description

National multicenter registry in Brazil with initial plan of 25 sites from the 5 Brazilian regions. It will be coordinated by HCOR Research Institute which will perform regulatory, data and site management beyond academic leadership.NEAT is an observational cohort (Prospective registry of real world data) of patients with coronary and peripheral artery disease in an outopatient setting with 12 months of follow-up with collection of data at baseline, 6 months and 12 months.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients ≥45 years followed in ambulatory setting with ≥1 of the following 3 criteria:

1. Documented coronary disease (≥1 criteria must apply):

   • Stable angina
   • History of Unstable Angina
   • History of coronary angioplasty/stenting
   • History of coronary artery bypass graft
   • Myocardial infarction within the last 20 years

2. Documented symptomatic Peripheral Arterial Disease (≥1 criteria must apply):

   • Previous aorto-femoral bypass surgery, limb bypass surgery, or percutaneous transluminal angioplasty revascularization of the iliac, or infra-inguinal arteries, or
   • Previous limb or foot amputation for arterial vascular disease, or
   • History of intermittent claudication and one or more of the following: 1) An ankle/arm blood pressure (BP) ratio < 0.90, or 2) Significant peripheral artery stenosis (≥50%) documented by angiography, or by duplex ultrasound.

Exclusion criteria

• Patients from institutions that don't provide the Institutional Authorization Term,
• Incapacity of follow-up in one year according to investigator judgment (severe neuropsychiatric condition, life expectancy < 12 months)